PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,630 | -25.5% | 1,000 | 0.0% | 0.00% | – |
Q2 2023 | $3,530 | +14.2% | 1,000 | 0.0% | 0.00% | – |
Q1 2023 | $3,090 | -27.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2022 | $4,230 | +111.5% | 1,000 | 0.0% | 0.00% | – |
Q3 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q1 2022 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
Q4 2021 | $3,000 | -50.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2021 | $6,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
Q2 2021 | $8,000 | -11.1% | 1,000 | 0.0% | 0.00% | – |
Q1 2021 | $9,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2020 | $9,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q3 2020 | $9,000 | -10.0% | 1,000 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $10,000 | +25.0% | 1,000 | 0.0% | 0.00% | 0.0% |
Q1 2020 | $8,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
Q4 2019 | $8,000 | -27.3% | 1,000 | 0.0% | 0.00% | -100.0% |
Q3 2019 | $11,000 | -8.3% | 1,000 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $12,000 | -68.4% | 1,000 | 0.0% | 0.00% | -66.7% |
Q1 2019 | $38,000 | +8.6% | 1,000 | +181.7% | 0.00% | 0.0% |
Q4 2017 | $35,000 | -23.9% | 355 | -8.0% | 0.00% | -40.0% |
Q3 2017 | $46,000 | – | 386 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
TOBAM | 318,384 | $23,994,000 | 0.94% |
Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |